Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thirty-six-hour preoperative high-dose methotrexate infusion in patients with squamous carcinoma of the head and neck.

Thirty-six-hour preoperative high-dose methotrexate infusion in patients with squamous carcinoma of the head and neck. Med Pediatr Oncol. 1979; 6(1):39-45.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.